Abiopharma

Clinical trial NCT07403968: start date: 2026-05-16 → 2026-06-15.

Clinical trial NCT05922371 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-03-01 → 2025-07-04 3. primary completion date: 2025-02-01 → 2025-07-04 4. enrollment: 500 → 34 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06492707: status: SUSPENDED → RECRUITING.

Clinical trial NCT05404139 updates: 1. completion date: 2026-03-01 → 2031-02-01 2. primary completion date: 2026-03-01 → 2031-02-01

Clinical trial NCT04516369 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-22 → 2026-05-19

Clinical trial NCT07216573: start date: 2026-04-01 → 2026-05-07.

Clinical trial NCT05777031 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 22 → 12 participants 3. enrollment type: ESTIMATED → ACTUAL 4. collaborators added: Endo USA Inc., a Keenova Therapeutics Company 5. collaborators removed: Endo Pharmaceuticals

Clinical trial NCT04380350 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-03-30 → 2026-02-12 3. primary completion date: 2026-09-30 → 2026-02-12

National HealthCare Corporation Acquires Five Skilled Nursing Facilities in Strategic $50,500,000 Transaction

Clinical trial NCT06693960 updates: 1. completion date: 2025-12-31 → 2027-01-31 2. primary completion date: 2025-09-15 → 2026-12-15